GSK plc (GSK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 43.35 |
| Open | 43.48 |
| Bid | 43.82 x 3000 |
| Ask | 43.83 x 3200 |
| Day's Range | 43.41 - 43.95 |
| 52 Week Range | 37.80 - 46.97 |
| Volume | |
| Avg. Volume | 5,631,051 |
| Market Cap | 110.121B |
| Beta (5Y Monthly) | 0.37 |
| PE Ratio (TTM) | 19.05 |
| EPS (TTM) | 2.30 |
| Earnings Date | Feb 01, 2017 - Feb 06, 2017 |
| Forward Dividend & Yield | 1.99 (4.59%) |
| Ex-Dividend Date | May 19, 2022 |
| 1y Target Est | 49.81 |
- Business Wire
GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community
PHILADELPHIA, June 29, 2022--GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community
- Zacks
GlaxoSmithKline (GSK) Stock Moves -0.8%: What You Should Know
GlaxoSmithKline (GSK) closed the most recent trading day at $43.35, moving -0.8% from the previous trading session.
- Zacks
Gilead (GILD) Resubmits NDA for HIV Inhibitor to the FDA
Gilead (GILD) announces the resubmission of the NDA for lenacapavir, an investigational, long-acting HIV-1 capsid inhibitor, for the treatment of HIV-1 infection in the United States.
© 2022 Yahoo. All rights reserved.
